| Name | Title | Contact Details |
|---|
Nestlé Skin Healths mission is to enhance peoples quality of life and contribute to a healthier future through science-based solutions for skin health, leading to our vision - to change the way the world thinks about skin health. As one of the categorys leading companies, Nestlé Skin Health conducts ground-breaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health.
At Jack Nathan Health, we are committed to improving access to public health care to over 1.1 million patients per-year by delivering consistent, quality care in state-of-the-art medical and dental clinics in Walmart stores across Canada. Jack Nathan Health is proud to partner with Walmart Canada to deliver quality health care services and convenience to its customers. Walmart currently operates over 390 stores and serves more than 1 million customers each day across Canada. They are the third largest employer in Canada with more than 90,000 associates and offer a full range of groceries, general merchandise and specialty services - including Medical & Dental Clinics - under one roof.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
CC Ford Group is a Bernardsville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dci Biologicals Wichita Falls is a Wichita Falls, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.